Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Developing a Universal Diagnostic Algorithm for Hematologic Malignancies Based on Flow Cytometry and Single-Cell Transcriptomics

Dr. Elena Novak*
Department of Molecular Diagnostics, Charles University Faculty of Medicine, Czech Republic
*Corresponding Author: Dr. Elena Novak, Department of Molecular Diagnostics, Charles University Faculty of Medicine, Czech Republic, Email: elena.n@gmail.com

Received Date: Mar 01, 2025 / Accepted Date: Mar 31, 2025 / Published Date: Mar 31, 2025

Citation: Elena N (2025) Developing a Universal Diagnostic Algorithmfor Hematologic Malignancies Based on Flow Cytometry and Single-CellTranscriptomics. J Cancer Diagn 9: 291.

Copyright: © 2025 Elena N. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

Hematologic malignancies encompass a heterogeneous group of disorders, including leukemias, lymphomas, and myelomas, characterized by abnormal proliferation and differentiation of blood or bone marrow cells. Traditional diagnostic methods rely on morphology, immunophenotyping via flow cytometry, cytogenetics, and molecular assays. However, challenges persist in achieving early and precise diagnosis, especially in cases with ambiguous phenotypes or overlapping features. Recent advances in single-cell transcriptomics (scRNA-seq) offer unparalleled resolution of cellular heterogeneity and gene expression, while flow cytometry remains a gold standard for immunophenotyping. This article presents a comprehensive overview of a proposed universal diagnostic algorithm that integrates flow cytometry with single-cell transcriptomics to improve the classification, diagnosis, and subtyping of hematologic malignancies. The combined approach promises a scalable, data-rich, and precise diagnostic solution for routine clinical use.

Top Connection closed successfully.